首页> 外文期刊>Journal of the American Chemical Society >Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53
【24h】

Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53

机译:富含卤素的片段文库作为p53突变药物抢救的先导

获取原文
获取原文并翻译 | 示例
           

摘要

The destabilizing p53 cancer mutation Y220C creates a draggable surface crevice. We developed a strategy exploiting halogen bonding for lead discovery to stabilize the mutant with small molecules. We designed halogen-enriched fragment libraries (HEFLibs) as starting points to complement classical approaches. From screening of HEFLibs and subsequent structure-guided design, we developed substituted 2-(aminomethyl)-4-ethynyl-6-iodophenols as p53-Y220C stabilizers. Crystal structures of their complexes highlight two key features: (ⅰ) a central scaffold with a robust binding mode anchored by halogen bonding of an iodine with a main-chain carbonyl and (ⅱ) an acetylene linker, enabling the targeting of an additional subsite in the crevice. The best binders showed induction of apoptosis in a human cancer cell line with homozygous Y220C mutation. Our structural and biophysical data suggest a more widespread applicability of HEFLibs in drag discovery.
机译:不稳定的p53癌症突变Y220C产生可拖动的表面缝隙。我们开发了一种利用卤素键进行铅发现的策略,以稳定具有小分子的突变体。我们设计了富含卤素的片段库(HEFLibs)作为补充经典方法的起点。通过筛选HEFLib和后续的结构指导设计,我们开发了取代的2-(氨基甲基)-4-乙炔基-6-碘酚作为p53-Y220C稳定剂。它们的配合物的晶体结构突出了两个关键特征:(ⅰ)具有牢固结合模式的中央支架,该结合模式通过碘与主链羰基的卤素键结合而锚定,并且(ⅱ)乙炔接头,从而可以靶向其他亚基。缝隙。最好的结合剂显示出在具有纯合Y220C突变的人类癌细胞系中诱导凋亡。我们的结构和生物物理数据表明,HEFLibs在药物发现中具有更广泛的适用性。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2012年第15期|p.6810-6818|共9页
  • 作者单位

    Laboratory for Molecular Design and Pharmaceutical Biophysics, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard-Karls-University Tuebingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany,MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 OQH, United Kingdom;

    MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 OQH, United Kingdom;

    Laboratory for Molecular Design and Pharmaceutical Biophysics, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard-Karls-University Tuebingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany;

    MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 OQH, United Kingdom;

    MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 OQH, United Kingdom;

    MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 OQH, United Kingdom;

    Laboratory for Molecular Design and Pharmaceutical Biophysics, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard-Karls-University Tuebingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号